We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Triglyceride Glucose-Waist Height Ratio Index as a Predictor of Cardiometabolic Multimorbidity in Chinese Middle-Aged and Older Adults: Insights from a National Prospective Cohort Study

MedXY Editorial Team•Oct 19, 2025•Cardiology
Cardiometabolic multimorbidityCentral Adiposityinsulin resistanceRisk Prediction

Highlight

  • The triglyceride glucose-waist height ratio (TyG-WHtR) index integrates metabolic and anthropometric markers, predicting cardiometabolic multimorbidity (CMM) risk.
  • A prospective cohort of 4393 Chinese adults aged ≥45 showed a dose-dependent increase in CMM risk across TyG-WHtR quartiles over 9 years.
  • TyG-WHtR enhanced predictive accuracy and risk reclassification beyond conventional risk factors for CMM.
  • Findings support TyG-WHtR as a practical, accessible marker for early identification and prevention strategies targeting CMM in aging populations.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Harnessing Explainable Machine Learning for Personalized Obesity Hypoventilation Syndrome Risk Prediction in Bariatric Surgery CandidatesAn explainable machine learning model identifies bariatric surgery candidates at risk for obesity hypoventilation syndrome using seven accessible clinical variables, enhancing early diagnosis and perioperative risk management.Sep 27, 2026Insights from Neuron-Derived Extracellular Vesicle Biomarkers: PPARγ and GLP1 Receptor Agonists Modulate Brain Metabolism in CNS Insulin ResistanceThis review synthesizes clinical trial evidence showing that PPARγ and GLP1 receptor agonists modulate brain insulin signaling biomarkers in neuropsychiatric and neurodegenerative disorders, revealing CNS-specific metabolic effects beyond pSep 23, 2026Identifying and Mitigating Risk Factors for Intracranial Haemorrhage Following Tenecteplase Fibrinolysis in Acute Myocardial InfarctionThis study evaluates risk factors for intracranial haemorrhage after tenecteplase fibrinolysis in STEMI patients, developing a prediction model highlighting age, blood pressure, sex, weight, and dose interactions as key determinants.Sep 23, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Advancing Prognostic Precision in HFpEF: The LIFE-Preserved Risk Prediction Model
The LIFE-Preserved model accurately predicts short-term and lifetime risks of heart failure hospitalization or cardiovascular death in HFpEF patients, enabling tailored clinical risk stratification and improved management.
Sep 11, 2026
Predicting Hypothyroidism After Hemithyroidectomy: Development and Validation of a Clinical Nomogram for Personalized Risk AssessmentA validated nomogram predicts hypothyroidism risk within 12 months after hemithyroidectomy using clinical and pathological variables, aiding tailored patient counseling and postoperative monitoring.Sep 5, 2026
Harnessing Artificial Intelligence for Early Detection of Ovarian Cancer: Development and Validation of a Predictive Risk ModelA novel AI-driven risk prediction model for ovarian cancer demonstrates high accuracy and potential to improve early detection in screening settings.Aug 31, 2026